Emicizumab In a Preterm Infant with Severe Hemophilia A – RPTH
RPTH Journal shared a post on LinkedIn about a recent article by Eman Hassan et al, adding:
”Emicizumab in a preterm infant with severe hemophilia A
Emicizumab has transformed prophylaxis in hemophilia A, but data in preterm and very low-birth-weight infants are virtually nonexistent.
What do you do when a baby is born at 30 weeks with severe HA and a high risk of intracranial hemorrhage?
A new case report in RPTH Journal describes exactly this scenario and the multidisciplinary decision-making behind it.
Key details:
- Male infant born at 30+4 weeks to a known HA carrier
- Severe HA confirmed; intracranial hemorrhage excluded on cranial ultrasound
- Emicizumab prophylaxis initiated at just 26 hours of life
- Loading phase completed and maintenance dosing achieved with no bleeding, thrombosis, or adverse events”
Title: Emicizumab prophylaxis in a preterm infant with severe hemophilia A: a case report on the feasibility of early use
Authors: Eman Hassan, Charles Percy, Amna Ahmed, Gillian Lowe, Will Lester, Neil V. Morgan, Jayashree Motwani
Read the Full Article on RPTH Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?